Sign in

CIK 0001326205

  • Non-accelerated filer
  • Smaller reporting company

IGC Pharma, Inc.

Sign in to watch
Ticker
IGC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MD
Entity type
Operating
EIN
202760393
Phone
+1 301-529-4996
Business address
10224 FALLS ROAD, POTOMAC, MD, 20854
Former names
India Globalization Capital, Inc.
  1. 5 Insider Annual Insider Trading Report
  2. 5 Insider Annual Insider Trading Report
  3. 5 Insider Annual Insider Trading Report
  4. 4 Grant or award Director acquired 150,000 shares (grant or award)
  5. 4 Open-market sale Director sold 50,000 shares at an average $1.08 ($54,000)
  6. 4 Grant or award Vice President & PFO acquired 300,000 shares (grant or award)
  7. 4 Grant or award Exec. Chairman & CEO acquired 750,000 shares (grant or award)
  8. 4 Grant or award Manager and PAO acquired 30,000 shares (grant or award)
  9. 4 Open-market sale Vice President and PFO sold 116,020 shares at $2.00 ($232,040)
  10. 4 Open-market sale Exec. Chairman & CEO sold 50,000 shares at $1.87 ($93,260)
  11. 4 Open-market sale Exec. Chairman & CEO sold 200,000 shares at an average $1.04 ($207,098)
  12. 4 Grant or award Director acquired 215,000 shares (grant or award)
  13. 4 Open-market sale Vice President and PFO sold 50,000 shares at $1.10 ($55,000)
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 5 Insider Annual Insider Trading Report
  17. 5 Insider Annual Insider Trading Report
  18. 5 Insider Annual Insider Trading Report
  19. 4 Open-market sale Exec. Chairman & CEO sold 36,000 shares at an average $1.09 ($39,162)
  20. 4 Open-market sale Exec. Chairman & CEO sold 50,000 shares at an average $0.76 ($37,750)

Page 4 of 8 · 156 filings